Accepted at 1:48 a.m. Feb, 08, 2024 by Cameron
Author: aavila24
Co-authors: Cameron
Related Note: 1505264744581 1
Rationale for change

monobactam & amingoglycoside coverage overlap & ADR reminder
Source: AMBOSS - https://next.amboss.com/us/article/mm0VTg?q=antibotics%20overview

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Other::Only_Step_1 #AK_Step1_v12::#OME_banner #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::09_Aztreonam::*Monobactams #AK_Step1_v12::#B&B::14_Infectious_Disease::03_Antibiotics::02_Beta_Lactams::Extra #AK_Step1_v12::#Low/HighYield::3-HighYield-temporary #AK_Step1_v12::#Physeo::09_Pharm::05_Antibiotics::07_Monobactams #AK_Step2_v12::#B&B::08_Infectious_Disease::01_Antibiotics::02_Beta_Lactams::Extra #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::10_Carbapenems_and_Monobactams #AK_Other::#AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::01_Cell_Wall_&_Membrane-Active_Antibiotics::05_Monobactams_&_Carbapenems